U.S. Markets closed
  • S&P 500

    3,585.62
    -54.85 (-1.51%)
     
  • Dow 30

    28,725.51
    -500.10 (-1.71%)
     
  • Nasdaq

    10,575.62
    -161.89 (-1.51%)
     
  • Russell 2000

    1,664.72
    -10.21 (-0.61%)
     
  • Crude Oil

    79.69
    -1.54 (-1.90%)
     
  • Gold

    1,669.00
    +0.40 (+0.02%)
     
  • Silver

    19.04
    +0.33 (+1.75%)
     
  • EUR/USD

    0.9801
    -0.0018 (-0.1862%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • Vix

    31.62
    -0.22 (-0.69%)
     
  • GBP/USD

    1.1166
    +0.0043 (+0.3841%)
     
  • USD/JPY

    144.7290
    +0.2860 (+0.1980%)
     
  • BTC-USD

    19,410.85
    -80.24 (-0.41%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

Solésence Beauty Science to Exhibit Cosmetics Infused with SPF at MakeUp In New York

·2 min read
Nanophase Technologies Corporation
Nanophase Technologies Corporation

ROMEOVILLE, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced that Solésence Beauty Science will be exhibiting at MakeUp in New York on September 14th and 15th, 2022.

MakeUp in New York is “a professional and convivial event connecting the most innovative and talented cosmetic suppliers with the most successful skincare and make-up brands,” according to the event website. Solésence Beauty Science, a leader in inclusive, mineral-based beauty products for skincare and makeup brands, will be exhibiting at MakeUp in New York for the first time. Solésence will showcase its market-ready products that embrace self-expression, health care, and self-care, blurring skin care with color cosmetics while providing best-in-class UV and environmental protection. Their award-winning formula, Multi-Cultural Magic SPF 50+ featuring Kleair™, will be at the show.

The announcement comes on the heels of Solésence being shortlisted as a finalist for Best Contract Manufacturer in the BeautyMatter NEXT Awards.

“We are thrilled to join other industry leaders across makeup and skincare categories at MakeUp in New York. We chose to participate on a last-minute basis in response to requests from both current and prospective brand partners. Coupled with the increased interest in SPF-infused beauty products across the industry, we are expecting a busy show. We look forward to seeing familiar faces as well as making the acquaintance of some new ones,” commented Kevin Cureton, Chief Operating Officer.

About Solésence Beauty Science
Solésence, LLC, www.solesence.com, a wholly owned subsidiary of Nanophase Technologies, is changing the face of skin health with patented, mineral-based technology that is embraced by leading performance-driven and clean beauty brands alike. Our patented products for brands transform the way mineral actives look, feel and function — enabling textures never-before-seen in the mineral space and inclusivity never-before-seen in the sun care space. Solésence’s innovative formulations offer best-in-class UV protection, unparalleled free radical prevention to protect against pollution, and enhanced antioxidant performance.

About Nanophase Technologies
Nanophase Technologies Corporation (OTCQB: NANX), www.nanophase.com, is a leading innovator in minerals-based and scientifically driven health care solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated, patented, and proprietary technologies, the Company creates products with unique performance, enhancing consumers' health and wellbeing. We deliver commercial quantity and quality engineered materials both as ingredients and as part of fully formulated products in a variety of formats.

Forward-Looking Statements
This press release contains words such as “expects,” shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2022. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.

Media Contact:
Emma Harper
Email: eharper@solesence.com
Phone: (630) 686-1574

Investor Relations Contact:
Phone: (630) 771-6736